Theravance Biopharma Inc (TBPH) Company Profile & Statistics

Theravance Biopharma Inc
TBPH
(Nasdaq - US)
N/A
9.13
-0.01 (-0.11%)
in:usd•As of: Apr 26, 2024 15:59 UTC -4
Open
9.31
High
9.31
Low
9.11

About Theravance Biopharma Inc

CEO

Rick E Winningham

Headquarters

901 gateway boulevard

south san francisco, ca 94080, cayman islands

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

www.theravance.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.?

Theravance Biopharma Inc Statistics

Valuation Measures

Market Capitalization ²	443.35M
Enterprise Value	403.81M
Enterprise Value/EBITDA (ttm)	-7.22
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.14
Price to Sales (ttm)	7.73
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-93.28%
Profit Margin (ttm)	-107.83%
Return on Equity (ttm)	-19.31%
Return on Invested Capital (ttm)	-19.18%
Return on Assets (ttm)	-12.03%

Income Statement

Revenue (ttm)	57.42M
Revenue Per Share (ttm)	1.19
Gross Profit (ttm)	57.42M
EBITDA (ttm)³	-55.93M
Net Income Avi to Common (ttm)	-55.19M
Diluted EPS (ttm)	-0.97

Share Statistics

Beta (5Y Monthly)	0.36
52-Week Change	-15.54%
S&P500 52-Week Change	25.74%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	48.16M
Dividend Yield	0.00%
Float ⁴	45.21M
% Held by Insiders	6.90%
% Held by Institutions	99.10%

Balance Sheet

Total Cash (mrq)	102.43M
Total Cash Per Share (mrq)	2.13
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	5.39%
Quick Ratio (mrq)	5.39%
Book Value Per Share (mrq)	4.43

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.49
Free Cash Flow (ytd)	-27.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Theravance Biopharma Inc

Trade With A Regulated Broker